These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34406225)

  • 41. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 42. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):e119-e153. PubMed ID: 27287213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Williams PM; Conklin RJ
    Dent Clin North Am; 2005 Jan; 49(1):67-76, viii. PubMed ID: 15567361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethosuximide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap confirmed by patch testing in a child.
    Matos AL; Carvalho J; Calado R; Gomes T; Ramos L; Gonçalo M
    Contact Dermatitis; 2021 Nov; 85(5):602-604. PubMed ID: 34218457
    [No Abstract]   [Full Text] [Related]  

  • 48. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know!
    Kamolz LP; Spendel S; Prandl EC
    Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649
    [No Abstract]   [Full Text] [Related]  

  • 49. Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Stern RS
    Arch Dermatol; 2000 Mar; 136(3):410-1. PubMed ID: 10724207
    [No Abstract]   [Full Text] [Related]  

  • 50. Fatal bronchiolitis obliterans complicating Stevens-Johnson syndrome following treatment with nimesulide: a case report.
    Dogra S; Suri D; Saini AG; Rawat A; Sodhi KS
    Ann Trop Paediatr; 2011; 31(3):259-61. PubMed ID: 21781423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome.
    Date H; Sano Y; Aoe M; Goto K; Tedoriya T; Sano S; Andou A; Shimizu N
    J Thorac Cardiovasc Surg; 2002 Feb; 123(2):389-91. PubMed ID: 11828317
    [No Abstract]   [Full Text] [Related]  

  • 53. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 54. Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease.
    González-Ramos J; Lamas C; Bellón T; Ruiz-Bravo E; RamIrez E; Lerma V; Lecumberri B
    Indian J Dermatol Venereol Leprol; 2020; 86(5):515-518. PubMed ID: 30688217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Review of the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Woolum JA; Bailey AM; Baum RA; Metts EL
    Adv Emerg Nurs J; 2019; 41(1):56-64. PubMed ID: 30702535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
    J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
    Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
    Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxic epidermal necrolysis: a paradigm of critical illness.
    Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
    Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
    Tartarone A; Lerose R
    Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.